drugset / Trial / NCT02695446
Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the skin and plasma concentrations of minocycline in subjects undergoing treatment of acne vulgaris with oral extended release minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-04
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minocycline | Small molecule | 2 mg/kg | Oral |